Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

Affiliations

• ¹ Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. [email protected].
• ² Pediatric Surgical Oncology, National Cancer Center Hospital, Tokyo, Japan. [email protected].
• ³ Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
• ⁴ Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
• ⁵ Pediatrics, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁶ Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan.
• ⁷ Pediatric Surgery, Osaka City General Hospital, Osaka, Japan.
• ⁸ Kobe Proton Center, Kobe, Japan.
• ⁹ Pathology, National Center for Child Health and Development, Tokyo, Japan.
• ¹⁰ Clinical Epidemiology Research Center for Pediatric Cancer, National Center for Child Health and Development, Tokyo, Japan.
• ¹¹ Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
• ¹² National Institute of Public Health, Saitama, Japan.
• ¹³ Pediatrics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
• ¹⁴ Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
• ¹⁵ Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan.
• ¹⁶ Ibaraki Prefectural Association of Health Evaluation and Promotion, Mito, Japan.
• ¹⁷ Pediatric Surgery, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
• ¹⁸ Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
• ¹⁹ Saga Medical Center, KOSEIKAN Hospital, Saga, Japan.